MARKET

TELO

TELO

Telomir Pharms
NASDAQ
6.20
-0.64
-9.36%
After Hours: 5.99 -0.21 -3.39% 19:22 05/03 EDT
OPEN
6.63
PREV CLOSE
6.84
HIGH
6.63
LOW
6.00
VOLUME
15.05K
TURNOVER
0
52 WEEK HIGH
20.72
52 WEEK LOW
4.760
MARKET CAP
183.58M
P/E (TTM)
-12.9517
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TELO last week (0422-0426)?
Weekly Report · 6d ago
MRIN, WISA and SMFL among mid-day movers
On the Move MRIN, WISA and SMFL among mid-day movers in SA. Matterport, mF International and Edible Garden AG are among the Gainers. YY Group Holding Limited is one of the losers in SA's top 10 list of companies.
Seeking Alpha · 04/22 16:52
12 Health Care Stocks Moving In Monday's Intraday Session
NKGen Biotech (NASDAQ:NKGN) shares rose 33.8% to $1.48 during Monday's regular session. The company's, Q4 earnings came out 4 days ago. MSP Recovery shares rose 29.74% and Assure Hldgs stock increased by 24.31%. Losers include Vaxxinity, Ocean Biomedical and Telomir Pharmaceuticals.
Benzinga · 04/22 16:31
BUZZ-U.S. STOCKS ON THE MOVE-AZZ, Smartsheet, Zions Bancorporation
Wall Street's main indexes rose on Monday after steep losses in the previous session. The Dow Jones Industrial Average was up 0.31% at 38,103.16. The top three S&P 500 percentage gainers were Ford Motor Co, Nvidia and Zions Bancorporation. Major tech earnings and a key inflation print are on the agenda this week.
Reuters · 04/22 16:17
Weekly Report: what happened at TELO last week (0415-0419)?
Weekly Report · 04/22 12:45
Telomir Pharmaceuticals Unveils Pre-Clinical Data On Age-Reversal Drug Telomir-1 At National Press Club Event in Washington, D.C.
Telomir-1 elongates telomere caps on human embryonic fibroblast cells by stimulating the enzyme telomerase that protects the DNA and genetic material in chromosomes to combat aging. Outlined timeline for initiating human investigational new drug trials for osteoarthritis.
Benzinga · 04/16 12:39
Telomir Pharmaceuticals Unveils Research Direction at NPC
TipRanks · 04/15 20:35
Weekly Report: what happened at TELO last week (0408-0412)?
Weekly Report · 04/15 12:35
More
About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. TELOMIR-1 serve as a metal enzyme inhibitor of essential metals such as zinc and copper. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The Company’s BioMAP platform provides an unbiased, target-agnostic, and data-driven approach to understanding the effect of mono- or combination therapies on human disease models and translational biomarkers.

Webull offers Telomir Pharmaceuticals Inc stock information, including NASDAQ: TELO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TELO stock methods without spending real money on the virtual paper trading platform.